<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Go to publication entry in University of Southern Denmark&apos;s Research Portal</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Accepted</forename><surname>Article</surname></persName>
						</author>
						<author role="corresp">
							<persName><roleName>Professor</roleName><forename type="first">Jean</forename><surname>Bousquet</surname></persName>
							<email>jean.bousquet@orange.fr</email>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="institution">University of Southern</orgName>
								<address>
									<country key="DK">Denmark</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff1">
								<orgName type="institution">University of Southern Denmark</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff2">
								<orgName type="department">30. Pneumology and Allergy Department Hospital Clínic, Clinical &amp; Experimental Respiratory Immunoallergy</orgName>
								<orgName type="institution">IDIBAPS</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff3">
								<orgName type="institution" key="instit1">CIBERES</orgName>
								<orgName type="institution" key="instit2">University of Barcelona</orgName>
								<address>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff4">
								<orgName type="institution" key="instit1">Skin and Allergy Hospital</orgName>
								<orgName type="institution" key="instit2">Helsinki University Hospital</orgName>
								<address>
									<settlement>Helsinki</settlement>
									<country key="FI">Finland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff5">
								<orgName type="department">Department of Otorhinolaryngology</orgName>
								<orgName type="institution">Academic Medical Centre</orgName>
								<address>
									<settlement>Amsterdam</settlement>
									<country key="NL">the Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff6">
								<orgName type="department">33. Division of Internal Medicine, Asthma and Allergy</orgName>
								<orgName type="institution" key="instit1">Barlicki University Hospital</orgName>
								<orgName type="institution" key="instit2">Medical University of Lodz</orgName>
								<address>
									<country key="PL">Poland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff7">
								<orgName type="department">Department of Dermatology and Allergy Centre</orgName>
								<orgName type="institution" key="instit1">Odense University Hospital</orgName>
								<orgName type="institution" key="instit2">Odense Research Center for Anaphylaxis (ORCA)</orgName>
								<address>
									<settlement>Odense</settlement>
									<country key="DK">Denmark</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff8">
								<orgName type="institution" key="instit1">Woolcock Institute of Medical Research</orgName>
								<orgName type="institution" key="instit2">University of Sydney</orgName>
								<orgName type="institution" key="instit3">Sydney Local Health District</orgName>
								<address>
									<settlement>Glebe</settlement>
									<region>NSW</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff9">
								<orgName type="department" key="dep1">Department of Allergy, Immunology and Respiratory Medicine</orgName>
								<orgName type="department" key="dep2">Central Clinical School</orgName>
								<orgName type="department" key="dep3">Department of Immunology</orgName>
								<orgName type="institution" key="instit1">Alfred Hospital</orgName>
								<orgName type="institution" key="instit2">Monash University</orgName>
								<address>
									<settlement>Melbourne</settlement>
									<region>Victoria</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff10">
								<orgName type="institution">Monash University</orgName>
								<address>
									<settlement>Melbourne</settlement>
									<region>Victoria</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff11">
								<orgName type="department">Department of ENT</orgName>
								<orgName type="institution">Medical University of Graz</orgName>
								<address>
									<country key="AT">Austria</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff12">
								<orgName type="department">Department of Pulmonology</orgName>
								<orgName type="institution">Celal Bayar University</orgName>
								<address>
									<settlement>Manisa</settlement>
									<country key="TR">Turkey</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff13">
								<orgName type="institution">GARD Executive Committee</orgName>
								<address>
									<country key="TR">Turkey</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff14">
								<orgName type="department" key="dep1">Department of Pulmonary Diseases</orgName>
								<orgName type="department" key="dep2">Faculty of Medicine</orgName>
								<orgName type="institution">Istanbul University</orgName>
								<address>
									<settlement>Cerrahpasa</settlement>
									<country key="TR">Turkey</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff15">
								<orgName type="department">ENT Dept</orgName>
								<orgName type="laboratory">Upper Airways Research Laboratory</orgName>
								<orgName type="institution">Ghent University Hospital</orgName>
								<address>
									<settlement>Ghent</settlement>
									<country key="BE">Belgium</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff16">
								<orgName type="department">Department of Microbiology and Immunology</orgName>
								<orgName type="laboratory">Laboratory of Clinical Immunology</orgName>
								<orgName type="institution">KU Leuven</orgName>
								<address>
									<settlement>Leuven</settlement>
									<country key="BE">Belgium</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff17">
								<orgName type="department">Department of Clinical Science and Education</orgName>
								<orgName type="institution">Karolinska Institutet</orgName>
								<address>
									<settlement>Södersjukhuset, Stockholm</settlement>
									<country key="SE">Sweden</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff18">
								<orgName type="department">43. Sachs&apos; Children and Youth Hospital</orgName>
								<orgName type="institution">Stockholm and Institute of Environmental Medicine</orgName>
								<address>
									<settlement>Södersjukhuset</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff19">
								<orgName type="institution">Karolinska Institutet</orgName>
								<address>
									<settlement>Stockholm</settlement>
									<country key="SE">Sweden</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff20">
								<orgName type="institution">Peercode DV</orgName>
								<address>
									<settlement>Gerdermalsen</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff21">
								<orgName type="institution">CHU Montpellier</orgName>
								<address>
									<addrLine>371 Avenue du Doyen Gaston Giraud</addrLine>
									<postCode>34295, Cedex 5</postCode>
									<settlement>Montpellier</settlement>
									<country>France Tel</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Go to publication entry in University of Southern Denmark&apos;s Research Portal</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">1DC1F18A89DE6D017F0560C714254A7A</idno>
					<idno type="DOI">10.1111/all.13307</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:26+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>rhinitis</term>
					<term>EQ-5D</term>
					<term>ARIA</term>
					<term>MASK</term>
					<term>WPAI-AS</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>The Allergic Rhinitis and its Impact on Asthma (ARIA) score of allergic rhinitis using mobile technology correlates with quality of life</s></p><p><s>The MASK study</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>Measures of allergic rhinitis (AR) control include symptom scores, patients' self-administered visual analogue scales (VAS), objective measures of nasal obstruction, a recent modification of the ARIA severity classification, or patients' reported outcomes such as QOL or scores with several items <ref type="bibr">(1,</ref><ref type="bibr">2)</ref>.</s><s>Mobile technology has been used to appraise AR control <ref type="bibr" target="#b23">(3,</ref><ref type="bibr">4)</ref>.</s><s>More information is however needed to fully understand the importance of these novel approaches.</s></p><p><s>MASK-rhinitis (MACVIA-ARIA Sentinel NetworK for allergic rhinitis), an ICT system centred around the patient <ref type="bibr">(5)</ref>, is one of the implementation tools of the B3 Action Plan of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA) <ref type="bibr">(6)</ref>.</s><s>A mobile phone app (Allergy Diary) central to MASK-rhinitis belongs to the Fondation Partenariale FMC VIA-LR (Ministry of Education and Research, France).</s><s>App users are asked to complete a short demographic questionnaire, EQ-5D (7-10) and WPAI-AS <ref type="bibr" target="#b38">(11,</ref><ref type="bibr">12)</ref>, thus providing baseline characteristics of their disease.</s><s>The Allergy Diary has been launched in 21 countries <ref type="bibr" target="#b23">(3,</ref><ref type="bibr">4)</ref>.</s><s>It was found to be an easy and effective method of assessing symptoms of AR and work productivity.</s><s>The ARIA score is also available in the Allergy Diary adding the four components of the impact of AR (sleep, work and school performance, daily activities and bothersome symptoms).</s></p><p><s>The ARIA score of the Allergy Diary was compared with QOL scores of EQ-5D (7-10) and WPAI-AS <ref type="bibr" target="#b38">(11,</ref><ref type="bibr">12)</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Design of the study</head><p><s>A cross-sectional study on a self-selected population was carried out from June 1, 2016 to June 1, 2017.</s><s>EQ-5D (7-10) and/or WPAI-AS <ref type="bibr" target="#b38">(11,</ref><ref type="bibr">12)</ref> questionnaires are only available in some countries and not all of the Allergy Diary users filled in these questionnaires as they are optional.</s><s>All users filled in the ARIA score.</s><s>The ARIA score was compared with the EQ-5D visual analogue scale (VAS) and Question 9 (degree allergy affected regular activities) of the WPAI-AS.</s></p><p><s>The study is reported according to STROBE.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Setting and users</head><p><s>All consecutive users from June 1, 2016 to June 1, 2017 who answered the questions of the EQ-5D (7-10) and/or WPAI-AS <ref type="bibr" target="#b38">(11,</ref><ref type="bibr">12)</ref> were included in the study in 18 countries.</s><s>Some demographic characteristics (age, sex, country and language) were recorded.</s><s>The App was used by people who found it on Internet, Apple App store, Google Play store or any other way.</s><s>A few users were clinic patients that were asked by their physicians to use the app.</s><s>However, due to anonymisation of data, no specific information was gathered.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Accepted Article</head><p><s>This article is protected by copyright.</s><s>All rights reserved.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Allergy Diary</head><p><s>The app collects information on AR symptoms experienced (nasal and ocular), disease type (intermittent/persistent), how symptoms impact users' lives, and type(s) of AR treatment used (Table <ref type="table">1</ref> online).</s><s>The system has been deployed in 21 countries and in 16 languages (translated and backtranslated, culturally adapted and legally compliant).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Ethics</head><p><s>The Allergy Diary is CE1 registered but not considered by the Ethical Committee of the Cologne hospital of the MHRA (Medicines and Healthcare products Regulatory Agency -GOV.UK) as a medical device as it does not give any recommendations concerning treatment or diagnosis.</s><s>The terms of use, translated into all languages and customized according to each country's legislation, allow the use of the results for research purposes.</s><s>The data are anonymized except for geolocalized data that are never totally anonymous.</s><s>An Independent Review Board approval was not needed.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Outcomes</head><p><s>The ARIA score was calculated using the four Q4 questions of the Allergy Diary which include impact on daily activities, work and sleep and troublesome symptoms (Table <ref type="table">1</ref> online).</s><s>Each of the 4 items was ascribed a score of 1 ("Yes") or 0 ("No").</s><s>The total ARIA score ranged from 0 (no impairment) to 4 (severe impairment).</s></p><p><s>The electronic form of the EQ-5D-5L questionnaire (https://euroqol.org)</s><s>was applied in the 10 available languages (Danish, Dutch, English, Finnish, French, German, Italian, Polish, Portuguese, Spanish) (Online supplement 1) and we assessed the global VAS level and mobility impairment as this was an absent domain in the assessment of AR impairment.</s></p><p><s>The electronic form of the WPAI-AS questionnaire was applied in the 10 available languages (same as above for EQ-5D) <ref type="bibr" target="#b38">(11,</ref><ref type="bibr">12)</ref> according to the package obtained from Reilly and associates (www.reillyassociates.net/WPAI_General.html).</s><s>The percentage of impairment due to allergy for daily activities (Q9) was the outcome used.</s><s>(Online supplement 2).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Classification of users</head><p><s>Users with any positive answer to Q4 (Table <ref type="table">1</ref> online) were classified as "rhinitis" (score 0-4).</s><s>Those with a score of zero were classified as "no rhinitis" if they had no symptom (Q3, Table <ref type="table">1</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>online).</head><p><s>Those with a positive answer were classified as "rhinitis" (score 0).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical methods and analyses</head><p><s>Some users filled in EQ-5D or WPAI-AS more than once for a single day.</s><s>The first data were then used.</s><s>A non-Gaussian distribution was found for some of the data (Shapiro-Wilk test).</s><s>However, EQ-5D data are usually reported in means and SD.</s><s>Since the number of observations was large, we used parametric analyses.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Accepted Article</head><p><s>This article is protected by copyright.</s><s>All rights reserved.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Users</head><p><s>Of the 12,179 registered users, 1,287 filled in the EQ-5D questionnaire and 1,028 the WPAI-AS questionnaire (Table <ref type="table">2 online</ref>).</s><s>Among the 843 users who filled in both questionnaires, there were 507 women (60%) and 336 men (40%), with a mean (± SD) age of 35 ± 14 years.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Main results</head><p><s>Similar levels of EQ-5D VAS and WPAI-AS Q9 were found for users with no rhinitis and for those with an ARIA score of 0 to 2. There was a significant reduction of EQ-5D VAS levels and a significant increase of WPAI-AS Q9 levels in users with an ARIA score of 3 or 4 (Table <ref type="table">1</ref>).</s></p><p><s>The repartition of users for both EQ-5D and WPAI-AS (Figure <ref type="figure">1</ref>) shows that impairment occurred significantly more commonly for ARIA scores of 3 and 4 than for ARIA scores of 0-3.</s><s>There were from 12 to 16% of users with an EQ-5D VAS level ≥60 in ARIA scores 0-2 whereas the level increased to 26 and 27% in users with an ARIA score of 3 or 4.</s><s>There were from 19 to 31% of users with a Q9 ≥50 in ARIA scores of 0-2 whereas the level increased to 51 and 53% in users with an ARIA score of 3 or 4.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>This pilot study using mobile technology showed that QOL data (EQ-5D VAS and WPAI-AS Q9) are similar in users without rhinitis as in those with mild rhinitis (scores 0-2).</s><s>Users with a score of 3 or 4 had a significant impairment in QOL.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Strengths and limitations</head><p><s>The strengths and limitations of this study are those of mobile technology lengthily discussed previously <ref type="bibr" target="#b23">(3,</ref><ref type="bibr">4)</ref>.</s><s>In particular, there is a lack of patient characterization that is impossible using an App.</s><s>However, every observational study we have performed using the Allergy Diary has confirmed its interest and was able to identify users with a severe disease.</s><s>It is likely that mobile technology will become a very important tool for the understanding and management of AR.</s></p><p><s>One specific problem of the study is that there are more countries with EQ-5D or WPAI-AS reporting than translations in the App.</s><s>It is not known which translations were employed by users.</s></p><p><s>In this study, we did not perform sub-analyses assessing the importance of symptoms or other factors.</s><s>We did not investigate the treatments received.</s><s>As this is a pilot study, these analyses will be carried out once the number of users will have increased.</s></p></div>		</body>
		<back>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Accepted Article</head><p><s>This article is protected by copyright.</s><s>All rights reserved.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Accepted Article</head><p><s>This article is protected by copyright.</s><s>All rights reserved.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Generalizability</head><p><s>The EQ-5D scores observed in the study accord with those of previous studies <ref type="bibr">(8,</ref><ref type="bibr">10)</ref>.</s><s>Users with an ARIA score of 3 to 4 have a level similar to asthmatic patients with uncontrolled asthma <ref type="bibr" target="#b40">(13,</ref><ref type="bibr" target="#b41">14)</ref>.</s><s>Because of the equal weighing score of ARIA, it is difficult to know whether these differences may be due to specific symptoms (e.g.</s><s>sleep).</s><s>EQ-5D is a MAFEIP (Monitoring and assessment framework for the EIP on AHA) tool <ref type="bibr">(15)</ref> and the present study is in line with the EIP on AHA.</s><s>This is another important finding since the Transfer of Innovation of the Allergy Diary is an EIP on AHA scaling up project <ref type="bibr" target="#b43">(16)</ref>.</s></p><p><s>One of the major findings of the study is the very similar results with both tools supporting the use of the ARIA score to assess AR control using mobile technology.</s><s>The WPAI-AS scores observed in the study are lower than those reported in patients selected by physicians <ref type="bibr" target="#b38">(11,</ref><ref type="bibr">(17)</ref><ref type="bibr" target="#b45">(18)</ref><ref type="bibr" target="#b46">(19)</ref>.</s><s>This is because many users have mild rhinitis whereas in clinical trials or in patients selected by physicians AR is usually more severe.</s></p><p><s>This study also suggests that, in real life, there is a phenotype of severe AR that needs to be considered in terms of public health and cost savings since the severe form causes disability.</s><s>This phenotype is in focus in the Finnish Allergy Program <ref type="bibr">(20)</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Accepted Article</head><p><s>This article is protected by copyright.</s><s>All rights reserved.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<monogr>
		<author>
			<persName><surname>Macvia-France</surname></persName>
		</author>
		<title level="m">Contre les MAladies Chroniques pour un VIeillissement Actif en France European Innovation Partnership on Active and Healthy Ageing Reference Site</title>
				<meeting><address><addrLine>Montpellier, France</addrLine></address></meeting>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<monogr>
		<title level="m" type="main">VIMA : Ageing and chronic diseases Epidemiological and public health approaches</title>
		<author>
			<persName><surname>Inserm U 1168</surname></persName>
		</author>
		<idno>UMR-S 1168</idno>
		<imprint>
			<pubPlace>Villejuif, Université Versailles St-Quentin-en-Yvelines; Montigny le Bretonneux, France 3. Kyomed , Montpellier France</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">CUF Porto Instituto &amp; Hospital</title>
		<imprint/>
		<respStmt>
			<orgName>Center for Health Technology and Services Research-CINTESIS, Faculdade de Medicina, Universidade do Porto; and Allergy Unit</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Allergy Center, CUF-Descobertas Hospital</title>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<monogr>
		<title/>
		<author>
			<persName><surname>Imunoalergologia</surname></persName>
		</author>
		<imprint>
			<pubPlace>Portugal</pubPlace>
		</imprint>
		<respStmt>
			<orgName>Centro Hospitalar Universitário de Coimbra and Faculty of Medicine, University of Coimbra</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Paris</forename><surname>Epar U707 Inserm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Epar Umr-S</forename><surname>Upmc</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">I</forename><surname>Paris</surname></persName>
		</author>
		<imprint>
			<pubPlace>Paris, France</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">UPMC Paris 06</title>
		<idno>UMR-S 1136</idno>
	</analytic>
	<monogr>
		<title level="j">IPLESP, Equipe EPAR</title>
		<imprint/>
		<respStmt>
			<orgName>CHRU de Montpellier, Sorbonne Universités</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<monogr>
		<title level="m" type="main">Laboratoire de Pharmacologie Respiratoire UPRES EA220, Pôle des Maladies Respiratoires, Hôpital Foch</title>
		<imprint>
			<pubPlace>Suresnes Université Versailles Saint-Quentin, France</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<monogr>
		<title level="m" type="main">Team of Environmental Epidemiology applied to Reproduction and Respiratory Health</title>
		<author>
			<persName><forename type="first">Université</forename><surname>Inserm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Iab</forename><surname>Grenoble Alpes</surname></persName>
		</author>
		<imprint>
			<pubPlace>Grenoble, France</pubPlace>
		</imprint>
		<respStmt>
			<orgName>Université Joseph Fourier</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Department of Medicine, Surgery and Dentistry</title>
	</analytic>
	<monogr>
		<title level="j">Personalized Medicine Clinic Asthma &amp; Allergy</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">14</biblScope>
		</imprint>
		<respStmt>
			<orgName>Humanitas University ; University of Salerno ; University of Bari Medical School, Unit of Geriatric Immunoallergology</orgName>
		</respStmt>
	</monogr>
	<note>Scuola Medica Salernitana</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Brasil</title>
		<imprint/>
		<respStmt>
			<orgName>ProAR -Nucleo de Excelencia em Asma, Federal University of Bahia</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
	</analytic>
	<monogr>
		<title level="m">Florioanopolis, Brazil. 18. Center of Excellence in Asthma and Allergy</title>
				<meeting><address><addrLine>México, Mexico</addrLine></address></meeting>
		<imprint/>
		<respStmt>
			<orgName>Allergy Service, University Hospital of Federal University of Santa Catarina ; HU-UFSC</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Centro Médico Zambrano Hellion</title>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Comprehensive Allergy-Centre-Charité, Department of Dermatology and Allergy</title>
		<imprint/>
		<respStmt>
			<orgName>Charité -Universitätsmedizin Berlin</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<monogr>
		<title level="m" type="main">Global Allergy and Asthma European Network (GA 2 LEN)</title>
		<imprint>
			<pubPlace>Berlin, Germany</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Germany 23. Center for Rhinology and Allergology</title>
		<imprint/>
		<respStmt>
			<orgName>Institute of Social Medicine, Epidemiology and Health Economics, Charité -Universitätsmedizin Berlin, Berlin, and Institute for Clinical Epidemiology and Biometry, University of Wuerzburg</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<monogr>
		<title level="m">Germany. 25. iQ4U Consultants Ltd</title>
				<meeting><address><addrLine>London, UK</addrLine></address></meeting>
		<imprint/>
		<respStmt>
			<orgName>Institute of Medical Statistics, Informatics and Epidemiology, Medical Faculty, University of Cologne</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<monogr>
		<title level="m" type="main">Optimum Patient Care, Cambridge, UK, and Academic Centre of Primary Care</title>
		<imprint>
			<pubPlace>Singapore; Aberdeen, UK</pubPlace>
		</imprint>
		<respStmt>
			<orgName>Observational and Pragmatic Research Institute ; University of Aberdeen</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Asthma UK Centre for Applied Research</title>
		<imprint/>
		<respStmt>
			<orgName>Centre of Medical Informatics, Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh</orgName>
		</respStmt>
	</monogr>
	<note>Director</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<author>
			<persName><forename type="first">Centre</forename><surname>Isglobal</surname></persName>
		</author>
		<author>
			<persName><surname>For</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Barcelona; IMIM (Hospital del</title>
				<meeting><address><addrLine>Mar Research Institute</addrLine></address></meeting>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<monogr>
		<title level="m">CIBER Epidemiología y Salud Pública (CIBERESP), &amp; Universitat Pompeu Fabra (UPF)</title>
				<meeting><address><addrLine>Barcelona, Spain</addrLine></address></meeting>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">M</forename><surname>Schatz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">O</forename><surname>Meltzer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Nathan</surname></persName>
		</author>
		<imprint/>
	</monogr>
	<note>D validation of the rhinitis control asse evaluating rhinitis symptom control</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Helling MACVIA clinical decision algorithm</title>
		<author>
			<persName><forename type="first">J</forename><surname>Bousquet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Schunemann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">138</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="367" to="374" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<monogr>
		<title level="m" type="main">Arnavielhe S productivity in rhinitis using cell pho</title>
		<author>
			<persName><forename type="first">J</forename><surname>Bousquet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bewick</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Bedbrook A mobile phone technology in allergic</title>
		<author>
			<persName><forename type="first">J</forename><surname>Bousquet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">P</forename><surname>Caimmi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Allergy</title>
		<imprint>
			<biblScope unit="volume">72</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="857" to="865" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Care pathways implementing emergi asthma across the life cycle</title>
		<author>
			<persName><forename type="first">J</forename><surname>Bousquet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">W</forename><surname>Hellings</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Agache</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Tra</title>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<monogr>
		<title level="m" type="main">Aga for airway diseases</title>
		<author>
			<persName><forename type="first">J</forename><surname>Bousquet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Addis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Adcock</surname></persName>
		</author>
		<imprint>
			<publisher>AIRWAYS-ICP</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<monogr>
		<title level="m" type="main">Phillips KM between symptoms of allergic rhiniti Rhinol Allergy</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">P</forename><surname>Hoehle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Speth</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2017">2017</date>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="235" to="239" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<monogr>
		<title level="m">5D visual analogue scale (A) and WPAI-AS Q</title>
				<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Psychometri essment test: a brief patient-completed instrument for</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Derebery</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mintz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Stanford</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Allergy Asthma Immunol</title>
		<imprint>
			<biblScope unit="volume">104</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="118" to="124" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">m in adolescents and adults with allergic rhinitis</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">W</forename><surname>Gs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Arnavielhe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bachert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bedbrook</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Alle</title>
		<imprint>
			<biblScope unit="page">e2</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Wo ones: The MASK pilot study</title>
		<author>
			<persName><forename type="first">S</forename><surname>Mathieu-Dupas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Murray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bedbrook</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Allergy</title>
		<imprint>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">A</forename><surname>Bewick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hellings</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">W</forename><surname>Devillier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename></persName>
		</author>
		<imprint/>
	</monogr>
	<note>Pilot stu rhinitis in European countries: the MASK-rhinitis stud</note>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">ARIA 2 ing technologies for predictive medicine in rhinitis and ansl</title>
		<author>
			<persName><forename type="first">A</forename><surname>Bedbrook</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bachert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">C</forename><surname>Bergmann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Respir J</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="304" to="323" />
			<date type="published" when="2014">2016. 2014</date>
		</imprint>
	</monogr>
	<note>Allergy</note>
</biblStruct>

<biblStruct xml:id="b34">
	<monogr>
		<title level="m" type="main">Associati is with decreased general health-related quality of life</title>
		<author>
			<persName><forename type="first">M</forename><surname>Gaudin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Caradonna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Gray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">T</forename></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Estimating the severity distribution of disease in South Korea using EQ-5D-3L: a cross-sectional study</title>
		<author>
			<persName><forename type="first">M</forename><surname>Ock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Jo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">H</forename><surname>Gong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Sim</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Public Health</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page">234</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Patient related outcomes in a real life prospective follow up study: Allergen immunotherapy increase quality of life and reduce sick days</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">D</forename><surname>Petersen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Kronborg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Larsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Dahl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Gyrd-Hansen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">World Allergy Organ J</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">15</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Evaluating quality of life in patients with asthma and rhinitis: English adaptation of the rhinasthma questionnaire</title>
		<author>
			<persName><forename type="first">H</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Cisternas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">P</forename><surname>Katz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Omachi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Trupin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">H</forename><surname>Yelin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Allergy Asthma Immunol</title>
		<imprint>
			<biblScope unit="volume">106</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="110" to="118" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Severity and impairment of allergic rhinitis in patients consulting in primary care</title>
		<author>
			<persName><forename type="first">J</forename><surname>Bousquet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Neukirch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Bousquet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Gehano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Klossek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Le</forename><surname>Gal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">117</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="158" to="162" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Impact of ocular symptoms on quality of life (QoL), work productivity and resource utilisation in allergic rhinitis patients--an observational, cross sectional study in four countries in Europe</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Virchow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Demoly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mullol</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Canonica</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Higgins</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Med Econ</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="305" to="314" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Measurement of utility in asthma: evidence indicating that generic instruments may miss clinically important changes</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">W</forename><surname>Sullivan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">H</forename><surname>Ghushchyan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Campbell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Globe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Bender</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Magid</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Qual Life Res</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="3017" to="3026" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">1-year prospective real life monitoring of asthma control and quality of life in Italy</title>
		<author>
			<persName><forename type="first">C</forename><surname>Terzano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Cremonesi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Girbino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Ingrassia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Marsico</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Nicolini</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Respir Res</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page">112</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Development of a web-based tool for the assessment of health and economic outcomes of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA)</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Boehler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>De Graaf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Steuten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Abadie</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Med Inform Decis Mak</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>Suppl 3:S4</note>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) -Reference Site Twinning (EIP on AHA)</title>
		<author>
			<persName><forename type="first">J</forename><surname>Bousquet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Agache</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Aliberti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Angles</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Annesi-Maesano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Anto</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Allergy</title>
		<imprint>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Relationship of nasal congestion with sleep, mood, and productivity</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Stull</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Roberts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Frank</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Heithoff</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Med Res Opin</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="811" to="819" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Intranasal mometasone furoate therapy for allergic rhinitis symptoms and rhinitis-disturbed sleep</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">O</forename><surname>Meltzer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Munafo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Chung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Gopalan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">T</forename><surname>Varghese</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Allergy Asthma Immunol</title>
		<imprint>
			<biblScope unit="volume">105</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="65" to="74" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Estimate of the total costs of allergic rhinitis in specialized care based on real-world data: the FERIN Study</title>
		<author>
			<persName><forename type="first">C</forename><surname>Colas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Brosa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Anton</forename><forename type="middle">E</forename><surname>Montoro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Navarro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Dordal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Allergy</title>
		<imprint>
			<biblScope unit="volume">72</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="959" to="966" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Makela M, and the Allergy Programme Steering G. The Finnish Allergy Programme 2008-2018 works</title>
		<author>
			<persName><forename type="first">T</forename><surname>Haahtela</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Valovirta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bousquet</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Respir J</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="issue">6</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
